SIR, We thank Drs Pruzanski and Vadas for their interest in our paper' and for their positive comments.
We would like to add another interesting entity in which phospholipase A2 may have a role-that is, chronic anterior uveitis. In fact, we have studied aqueous humour from seven patients with chronic anterior uveitis for the activity of phospholipase A2. We found levels of phospholipase A2 significantly greater than those in aqueous humour from patients with senile cataracts. 2 It is interesting to note that phosphatidylcholine is readily degraded by aqueous humour phospholipase A2. On the other hand, lysophosphatidylcholine is known to harm the lens in experimental models of cataract development; so another possible role for phospholipase A2 in tissue damage should be added to the list. 1984 affecting the small joints of the hands, elbows, shoulders, neck, and ankles, with confirmatory erosions on x ray. Non-steroidal anti-inflammatory drugs provided little relief, and treatment was started with oral penicillamine, initially 250 mg daily and gradually increased to 625 mg. At this dose and three months after starting penicillamine the patient complained of a red itchy rash on her chest and neck. In view of the persisting activity of the rheumatoid arthritis without evidence of renal or haematological side effects treatment with penicillamine was continued orally at the lower dose of 500 mg daily. The skin rash persisted mildly with irritation. When the penicillamine was reduced to 250 mg daily a year later the patient felt that her skin rash improved. At this time she was seen in the dermatology outpatients' clinic.
Clinically she had morphoea lesions, hardened dermal plaques, on both sides of the chest, encircling both breasts, and on both sides of the abdomen (Fig. 1) . Symptoms of systemic sclerosis, including Raynaud's phenomenon, dysphagia, and dyspnoea, were absent. Her full blood count and erythrocyte sedimentation rate were normal with a mildly raised alkaline phosphatase and alanine transaminase consistent with the activity of her rheumatoid arthritis. Her rheumatoid factor and autoantibodies were negative, including antinuclear antibodies and antibodies against extractable nuclear and cytoplasmic antigens. Chest x ray was normal.
Histology of the skin lesion on her chest was consistent with morphoea. The keratin was normal and epidermis was mildly atrophic. In the dermis there was condensation of collagen, particularly in the deeper layers, with appendageal structures reduced in number and the remaining ones atrophic. Superficial capillaries were ectatic with an infiltrate of chronic inflammatory cells in a perivascular distribution. Direct immunofluorescent stains for IgG and IgA were also negative.
The penicillamine was discontinued at this time, and nine months later the morphoea has remained unchanged with no new lesions appearing. Her Fig. 1 Morphoea on the chest, encircling both breasts, and on the abdomen.
Penicillamine appears responsible for this patient's morphoea as there was a temporal relation, with initial improvement in symptoms on reduction of the dose and no progression of the morphoea on discontinuation.
Generalised morphoea has been described in association with rheumatoid arthritis.3 The association of morphoea with penicillamine is important, however, as penicillamine was logically used as a lathyrogenic agent in the treatment of scleroderma after an effect on the solubility of dermal collagen was observed. 
